Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates enhanced anticancer efficacy in a rat model, suggesting improved treatment outcomes.
of 153.57 μM as assessed by the MTT assay. PEG-LP-KP demonstrated a favorable safety profile, as evidenced by both acute and sub-acute toxicity assessments. We also found a significant tumor reduction in PEG-LP-KP treated animal groups compared to vehicle control as assessed by Orthotopic syngeneic N1S1 rat model.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: